Cardiometabolic Outcomes, Mechanisms and approach to prevention of Dolutegravir Associated Weight Gain In South Africa

Cardiometabolic Outcomes, Mechanisms and approach to prevention of Dolutegravir Associated Weight Gain In South Africa

Related Resources

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

HIV-associated Noncommunicable Diseases Research at LMIC Institutions

Project Information in NIH RePORTER

Cardiometabolic Outcomes, Mechanisms and approach to prevention of Dolutegravir Associated Weight Gain In South Africa

Principal Institution

University of Pittsburgh

Principal Investigator(s) (PI)

Nachega, Jean Bisimwa; Kengne, Andre Pascal

Year(s) Awarded

2020–2022

Country

South Africa

Related World Regions / Countries

Related Global Health Research Topics

  • HIV / AIDS